ETON PHARMACEUTICALS ($ETON) posted quarterly earnings results for Q2 2026 on Thursday, August 13th. The company reported earnings of $0.35 per share, beating estimates of $0.12 by $0.23. The company also reported revenue of $37,590,000, beating estimates of $27,655,260 by $9,934,740.
Stock price change since market close: +20.42%
You can see Quiver Quantitative's $ETON stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ETON PHARMACEUTICALS Insider Trading Activity
ETON PHARMACEUTICALS insiders have traded $ETON stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $ETON stock by insiders over the last 6 months:
- MANAGEMENT INC. OPALEYE has made 0 purchases and 7 sales selling 155,000 shares for an estimated $5,831,670.
- SEAN BRYNJELSEN (President & CEO) has made 0 purchases and 2 sales selling 120,000 shares for an estimated $3,825,716.
- DAVID KREMPA (Chief Business Officer) has made 0 purchases and 5 sales selling 100,000 shares for an estimated $3,229,923.
- JENNIFER MCKIE ADAMS sold 50,000 shares for an estimated $1,623,795
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ETON PHARMACEUTICALS Hedge Fund Activity
We have seen 92 institutional investors add shares of ETON PHARMACEUTICALS stock to their portfolio, and 45 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PILLSBURY LAKE CAPITAL LLC added 364,954 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,007,064
- NUVEEN, LLC added 317,757 shares (+548.3%) to their portfolio in Q2 2026, for an estimated $11,502,803
- MORGAN STANLEY added 290,015 shares (+60.7%) to their portfolio in Q2 2026, for an estimated $10,498,543
- JPMORGAN CHASE & CO added 191,635 shares (+inf%) to their portfolio in Q2 2026, for an estimated $6,937,187
- PANORAMIC CAPITAL, LLC added 185,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,565,800
- BLACKROCK, INC. added 178,547 shares (+10.4%) to their portfolio in Q2 2026, for an estimated $6,463,401
- STATE STREET CORP added 171,571 shares (+32.4%) to their portfolio in Q2 2026, for an estimated $6,210,870
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ETON PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $ETON recently. We have seen 3 analysts offer price targets for $ETON in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $57.0 on 05/15/2026
- Madison El-Saadi from B. Riley Securities set a target price of $31.0 on 03/20/2026
- Chase Knickerbocker from Craig-Hallum set a target price of $35.0 on 03/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
